Piramal Pharma Solutions launches Xcelerate platform

| By | CDMO, Drug Development, Piramal Pharma Solutions
0
45

Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch of its Xcelerate Integrated Solutions™ platform.

This platform will serve the increasing demand from pharmaceutical firms, both large and small, for preferred partnerships with organizations that can provide world-class solutions across a range of verticals – drug discovery, drug substance, drug product, and clinical trial services.

Recently, as Contract Manufacturing Organizations have developed scale and expertise across multiple verticals, customers have begun to consider ‘program based outsourcing’ for better efficiency on time, costs, and management.

The Xcelerate platform provides integrated solutions for orphan diseases, niche therapies, and fast track medicines, where the volume requirements are small, while also having the capacity and track record to address large volume needs of metabolic diseases and neuroscience therapies. The distinct footprint of PPS, with around half its sites in the East and the other half in the West, allows customers to manufacture the final API or Drug product out of the West, while back integrating into starting materials and intermediates out of its sites in the East.

PPS offers platform solutions from Discovery through Commercialization with 12 R&D and manufacturing locations across North America, Europe, and Asia. In parallel, PPS has also addressed gaps in its integrated offerings through both, acquisitions and internal investments. In oncology therapeutics Piramal now offers a unique platform that includes high potency API, fill-finish, and Antibody Drug Conjugation (ADC) solutions. The integrated capabilities are augmented by customized IT systems that allow for real time access on program progress.

Mr. Vivek Sharma, CEO, Piramal Pharma Solutions, commented:

“The Xcelerate platform sets the foundation through which customers can accelerate their programs from clinic through approval and launch. With a track record of successfully executing over 70 integrated programs in the recent past, and the associated learnings, we have now invested in capabilities and systems to provide a seamless experience to our customers.”

The company was founded in 2007 and is based in Lexington, Kentucky USA). As of January 16, 2015, Piramal Pharma Solutions Inc. operates as a subsidiary of Piramal Healthcare.